COGT Competitors & Alternatives
Compare Cogent Biosciences Inc with similar stocks in the same industry
Biotechnology
COGT
Main Stock$29.14
Tradestie Score
37
Market Cap
$1.97B
Revenue Growth
-1.0%
Analyst Upside
+91.2%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.54
|
$6.03B | - | 42 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$42.62
|
$6.02B | - | 49 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$144.37
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$64.56
|
$5.80B | 98.1 | 30 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$305.68
|
$5.20B | 42.0 | 50 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$64.69
|
$4.94B | - | 38 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.36
|
$4.93B | - | 44 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$47.15
|
$4.84B | - | 50 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More COGT Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry